% compared to the same period of last year. The drop in costs was in the same direction with the drop in revenue, yielding the gross profit of THB 71.38 million (51% of total revenue), down THB 57.48 million
expand 4 percent for the whole of 2017. The report showed that Thailand’s export was improved mainly from a global trade recovery in which agricultural and electronic products were major contributions. In
-of-sale in Asia including Taiwan, Vietnam, and from the point-of-sale in Russia as a result of economic recovery. During this quarter, the RPK of the Company grew by 11.8 percent while the growth in
% yoy) because EBITDA from FA business was lower due to stock loss as CPKO price drop. Moreover, the company recognized profit of THB 20 million from investments in the Thai Ethoxylate Company Limited
%. The amount consisted of both domestic and overseas sales at the ratio of approximately 47:53, respectively. The overseas sales of branded products by own manufacture grew by 11.6% offsetting the drop of
. Business Recovery from the COVID-19 According to an improvement of COVID-19 infection control, the easing lockdown measures and the reinstatement of economic activities, the Company set its strategies and
slower rate in March and reached its bottom in April (-8.1% YoY), it made a v-shape recovery with 18.0% growth in June, partly driven by additional supply of C-Vitt from capacity expansion. - While Q2’20
. Lately, general patient revenue, especially foreign patient revenue, had been greatly affected by the significant drop in service utilization rates due to the pandemic situation. However, the Company has
travelers segment revenue declined further due to border closure and travel restriction. In addition, NBTC’s mandate for free data & voice in Apr-May caused significant drop in prepaid top up, while the
the company achieved expansion loans target while the domestic economic recovery. The total income was 839.71 million baht, an increase of 92.04 million baht or 12.31%. Interest expenses were 222.13